Treatment and survival of patients with thyroid lymphoma: A population-based study with clinical and pathologic reviews

Clinical Lymphoma and Myeloma

Volumn 6, Issue 3, 2005, Pages 240-247

  Kuper Hommel, Marion J J ^a   Snijder, Simone ^b   Janssen Heijnen, Maryska L G ^c   Vreugdenhil, Art ^d   Noordijk, Ed M ^e   Kluin Nelemans, Hanneke C ^f   Coebergh, Jan Willem W ^c   van Krieken, Johan H J M ^g  

^a BERNHOVEN HOSPITAL   (Netherlands)

^b Integraal Kankercentrum West   (Netherlands)

^c The Netherlands   (Netherlands)

^d Department of Internal Medicine ^*  (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diffuse large B cell lymphoma; Disease stage; Extranodal marginal zone lymphoma; Non Hodgkin's lymphoma

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INCIDENCE; CANCER REGISTRY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE COURSE; DISSEMINATED CANCER; FEMALE; FOLLOW UP; HASHIMOTO DISEASE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OUTCOMES RESEARCH; OVERALL SURVIVAL; POPULATION RESEARCH; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SEX RATIO; SURVIVAL RATE; THYROID LYMPHOMA; THYROIDECTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE; ARTICLE; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PATHOLOGY; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 33644875056     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2005.n.052     Document Type: Article

References (47)

1. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol 1999; 26:316-323.
2. Souhami L, Simpson WJ, Carruthers JS. Malignant lymphoma of the thyroid gland. Int J Radiat Oncol Biol Phys 1980; 6:1143-1147.
3. Rasbach DA, Mondschein MS, Harris NL, et al. Malignant lymphoma of the thyroid gland: a clinical and pathologic study of twenty cases. Surgery 1985; 98:1166-1170.
4. Matsuzuka F, Miyauchi A, Katayama. S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 1993; 3:93-99.
5. Pedersen RK, Pedersen NT. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology 1996; 28:25-32.
6. Aozasa K, Inoue A, Tajima K, et al. Malignant lymphomas of the thyroid gland. Analysis of 79 patients with emphasis on histologic prognostic factors. Cancer 1986; 58:100-104.
7. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312:601-604.
8. Thieblemont C, Mayer A, Dumontet C, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002; 87:105-111.
9. Mauch PM, Armitage JO, Coiffier B, et al. Non-Hodgkin's Lymphomas: Special Topics. Philadelphia: Lippincott Williams & Wilkins; 2004:686.
10. Tsang RW, Gospodarowicz MK Sutcliffe SB, et al. Non-Hodgkins's lymphoma of the thyroid gland: prognostic factors and treatment outcome. The Princess Margaret Hospital Lymphoma Group. Int J Radiat Oncol Biol Phys 1993; 27:599-604.
11. Logue JP Hale RJ, Stewart AL, et al. Primary malignant lymphoma of the thyroid: a clinicopathological analysis. Int J Radiat Oncol Biol phys 1992; 22:929-933.
12. Ancombe AM, Wright DH. Primary malignant lymphoma of the thyroid- a tumour of mucosa-associated lymphoid tissue: review of seventy-six cases. Histopathology 1985; 9:81-97.
13. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987; 11:445-462.
14. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338:1175-1176.
15. Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988; 19:1315-1326.
16. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients, J Clin Oncol 1997; 15:1624-1630.
17. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16:2780-2795.
18. Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003; 101:2489-2495.
19. de Jong D, Boot H, van Heerde P, et al Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 1997; 112:1466-1474.
20. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17:1244.
21. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000; 36:69-86.
22. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17:3835-3849.
23. Pileri SA, Milani M, Fraternali-Orcioni G, et al. From the R.E.A.L. classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities? Ann Oncol 1998; 9:607-612.
24. Harris NL. Principles of the Revised European-American Lymphoma Classification (from the International Lymphoma Study Group). Ann Oncol 1997; 8(suppl 2):11-16.
25. Harris NL, Isaacson PG. What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites? Am J Clin Pathol 1999; 111 (1 suppl 1):S126-S132.
26. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas (author's transl). Strahlentherapie 1977; 153:218-221.
27. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329:987-994.
28. Muir CS. Cancer Incidence in Five Continents. Lyon: IARC Sci Publ 1992; (120):25-30.
29. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003; 21:4642-4649.
30. Derringer GA, Thompson LD, Frommelt RA, et al. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Patho1 2000; 24:623-639.
31. Tennvall J, Cavallin-Stahl E, Akerman M. Primary localized non-Hodgkin's lymphoma of the thyroid: a retrospective clinicopathological review. Eur J Surg Oncol 1987; 13:297-302.
32. Belal AA, Allam A, Kandil A, et al. Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma. Am J Clin Oncol 2001; 24:299-305.
33. Skacel M, Ross CW, Hsi ED. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma. Histopathology 2000; 37:10-18.
34. Singer JA. Primary lymphoma of the thyroid. Am Surg 1998; 64:334-337.
35. Liang R, Choy D, Chan TK, et al. Chemotherapy versus radiotherapy for stage I-II intermediate grade non-Hodgkin's lymphomas. Clin Oncol (R Coll Radiol) 1991; 3:335-339.
36. Hahn JS, Chung HC, Min YH, et al. Primary lymphoma of the thyroid. Yonsei Med J 1995; 36:315-321.
37. Chetty R, Bolding E, Johnson CA, et al. Primary thyroid lymphomas. A clinicopathological study of 8 cases. S Afr Med J 1990; 78:548-550.
38. Mizukami Y, Michigishi T, Nonomura A, et al. Primary lymphoma of the thyroid: a clinical, histological and immunohistochemical study of 20 cases. Histopathology 1990; 17:201-209.
39. Makepeace AR, Fermont DC, Bennett MH. Non-Hodgkin's lymphoma of the thyroid. Clin Radiol 1987; 38:277-281.
40. Compagno J, Oertel JE. Malignant lymphoma and other lymphoproliferative disorders of the thyroid gland. A clinicopathologic study of 245 cases. Am J Clin Pathol 1980; 74: 1-11.
41. Tsang RW, Gospodarowicz MK Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003; 21:4157-4164.
42. Schreuder MI, Hoeve MA, Hebeda KM, et al. Mutual exclusion of t(11;18)(q2l;q2l) and numerical chromosomal aberrations in the development of different types of primary gastric lymphomas. Br J Haematol 2003; 123:590-599.
43. Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18)(q2l;q2l) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 2003; 102:1012-1018.
44. Ha CS, Shadle KM, Medeiros LJ, et al. Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer 2001; 91:629-635.
45. Skarsgard ED, Connors JM, Robins RE. A current analysis of primary lymphoma of the thyroid. Arch Surg 1991; 126:1199-1203.
46. Tupchong L, Hughes F, Harmer CL. Primary lymphoma of the thyroid: clinical features, prognostic factors, and results of treatment. Int J Radiat Oncol Biol Phys 1986; 12:1813-1821.
47. Conconi A, Martinelli G, Thieblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102:2741-2745.